Tryp Therapeutics Explores Psilocybin’s Potential In New Trials To Treat IBS And Fibromyalgia
Psychedelics biotech Tryp Therapeutics (OTCQB: TRYPF) is advancing its psilocybin-based portfolio through several recent milestones.
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA’s Stance, The Therapist’s Role & More
Welcome to Benzinga's weekly psychedelics news roundup. We have pulled together several must-read news items from the last week of December 2023 and the first of January 2024.
Canadian Home Of Cookies, Sherbinskis And Wyld Cannabis Brands Acquired As BZAM Consolidates Market Presence
BZAM Ltd. has completed its previously announced acquisition of all of the issued and outstanding shares of Final Bell Canada Inc. from Final Bell Holdings International Ltd. Under the deal, FBHI, the sole shareholder of FBC, has obtained 90 million BZAM's common shares at $0.15 per share, The combined company will be the Canadian home of some of the most recognizable international brands in the cannabis industry – including Berner's Cookies, Sherbinskis and Wyld.
Five Stocks That Are Attractively Priced, Solid Credits, With Room To Run
The first week of 2024 saw significant stock price appreciation for most of the 30 stocks Viridian Capital Advisors credit ranks weekly. As a proxy, the MSOS ETV rose 12.84%, the sharpest uptick since the HHS announcement at the end of August. There was no particular news to account for the uptick except for confirmation from the DEA that they are indeed studying the issue of rescheduling.
Remembering The Weed-smoking Capitol Rioter Who Compared Himself To Elon Musk And Called Jan. 6 A ‘Beautiful Day’?
Brandon Fellows, who represented himself in trial wherein he was convicted of one felony count of obstruction and four misdemeanors for his role in the Jan. 6 Capitol riots, famously said in his opening statement that he didn’t see anything wrong with his actions. He called Jan.
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai’s $50M And More
Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury
Cheech & Chong Cannabis Products In New York, Terpene Cocktails And More Alternatives To Elevate Dry January
As Dry January encourages nationwide alcohol abstinence, the cannabis industry responds with new and alternative products, aligning with the shifting preferences of consumers exploring beyond traditional alcohol options since the challenge's inception in 20
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Pub
Florida GOP Representative Throws Wrench Into Proposed Cannabis Legalization Initiative With Bill To Cap THC Levels
Florida State Rep. Ralph Massullo (R) preemptively filed a bill on Friday that, if adopted, would impose limitations on the potency of marijuana ahead of the legalization initiative expected to appear on the ballot in November 2024.
Bullish Friday For Marijuana Stocks – Choom Holdings, EVIO Among Top Gainers
GAINERS: Choom Holdings (OTC:CHOOF) shares closed up 9900.00% at $0.0001 Affinor Growers (OTC:RSSFF) shares closed up 90.64% at…